Postanesthesia complications in pediatric patients with previous SARS‐CoV‐2 infection: A cohort study. Issue 1 (7th November 2022)

• Record Type: Journal Article
• Authors: Geng‐Ramos, Giuliana; Nelson, Jonathan; Lee, Angela C.; Deutsch, Nina; Challa, Chaitanya; Pestieau, Sophie; Rana, Md Sohel; Hubbard, Mark; Cronin, Jessica A.
• Is Part Of: Paediatric anaesthesia. Volume 33:Issue 1(2023)
• Page Start: 79
• Page End: 85
• Publication Date: 2022-11-07
• Subjects: complications -- COVID‐19 -- postanesthesia -- SARS‐CoV‐2; Pediatric anesthesia -- Periodicals; 617.96798
• DOI: 10.1111/pan.14585
• Languages: English
• ISSNs: 1155-5645

Abstract

Abstract: Background: Children with SARS‐CoV‐2 infection are at increased risk for postanesthesia complications. There is minimal data regarding how long that elevated complication risk persists beyond initial SARS‐CoV‐2 diagnosis. Aims: We investigated postanesthesia complications in children with SARS‐CoV‐2 infection within 90 days of diagnosis. Methods: We completed a single‐center, retrospective, case–control study of pediatric patients with confirmed SARS‐CoV‐2 infection within 90 days undergoing anesthesia between January 3–October 7, 2020. Each SARS‐CoV‐2 positive patient was matched 1:2 by age and type of procedure with a non–SARS‐CoV‐2 cohort. The primary outcome was the rate of all postanesthesia complications within 30 days of the procedure, defined as unplanned escalations of care within 48 h, cardiac, respiratory, thrombotic, and hemorrhagic events within 30 days. Secondary outcomes were 30‐day mortality and hospital length of stay. Results: Of the 341 patients included, 114 patients were SARS‐CoV‐2 positive and 227 were SARS‐CoV‐2 negative. Patients with a positive test 0–7 days prior to anesthesia had an increased risk difference in all postanesthesia complications within 30 days (19.9, 95% CI [4.7, 35.1], p = .001) and increased risk difference in length of hospital stay (7.8, 95% CI [1.2, 14.4], p < .001). Patients who underwent anesthesia greater than 42 days from SARS‐CoV‐2 diagnosis had an increased risk difference in cardiac complications within 30 days (4.3, 95% CI [0.9, 10.0], p = .029). There was no increased hospital length of stay among SARS‐CoV‐2 positive patients diagnosed greater than 8 days before anesthetic. There were no deaths within 30 days of anesthetic. Conclusions: Postanesthesia complications are higher in children who undergo anesthesia within 7 days of SARS‐CoV‐2 diagnosis. Additional cardiac risk may persist beyond the immediate period of initial diagnosis. Larger samples are needed to further evaluate the risk of delayed postanesthesia complications and guide optimal timing of surgery.